Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in nuclear medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.semnuclmed.2015.09.003PMID 26687858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review

  2015cited by this paper
• Beta-amyloid deposition in chronic traumatic encephalopathy

  2015cited by this paper
• Current thinking on the mechanistic basis of Alzheimer's and implications for drug development

  2015cited by this paper
• In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging

  2015cited by this paper
• Tau imaging: early progress and future directions.

  2015cited by this paper
• Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014

  2015cited by this paper
• Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel‐based analysis for entorhinal cortex atrophy

  2015cited by this paper
• Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.

  2015cited by this paper
• Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes

  2015cited by this paper
• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

  2015cited by this paper
• ammation and brain atrophy in former NFL players : An in vivo multimodal imaging pilot study

  2015cited by this paper
• The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

  2015cited by this paper
• Post-traumatic neurodegeneration and chronic traumatic encephalopathy.

  2015cited by this paper
• First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[18F]Flubatine

  2015cited by this paper
• The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

  2015cited by this paper
• Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

  2015cited by this paper
• White matter microstructural changes in pure Alzheimer's disease and subcortical vascular dementia

  2015cited by this paper
• NEUROSCIENCE. Alzheimer's amyloid theory gets modest boost.

  2015cited by this paper
• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2015cited by this paper
• Nicotinic ACh receptors as therapeutic targets in CNS disorders.

  2015cited by this paper
• Novel PET/SPECT Probes for Imaging of Tau in Alzheimer's Disease

  2015cited by this paper
• A review of β-amyloid neuroimaging in Alzheimer's disease

  2014influential reference
• Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old

  2014cited by this paper
• Human Brain Imaging of α7 nAChR with [18F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug Occupancy

  2014influential reference
• FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease

  2014cited by this paper
• An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease

  2014influential reference
• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

  2014cited by this paper
• Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions

  2014cited by this paper
• Brain PET in suspected dementia: patterns of altered FDG metabolism.

  2014influential reference
• [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy

  2014cited by this paper
• Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement

  2014influential reference
• In Vivo Imaging of Human Cholinergic Nerve Terminals with (–)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic Analyses

  2014cited by this paper
• Primary age-related tauopathy (PART): a common pathology associated with human aging

  2014cited by this paper
• Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

  2014cited by this paper
• Neuropsychology in Multidisciplinary Stroke Care: Clinical Feasibility of the NINDS-CSN Vascular Cognitive Impairment Harmonization Standards

  2014cited by this paper
• 18F-ASEM, a Radiolabeled Antagonist for Imaging the α7-Nicotinic Acetylcholine Receptor with PET

  2014cited by this paper
• Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

  2014cited by this paper
• Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury

  2014cited by this paper
• Tau PET Imaging in Alzheimer’s Disease

  2014cited by this paper
• Cholinergic Depletion in Alzheimer's Disease Shown by [18F]FEOBV Autoradiography

  2013cited by this paper
• Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

  2013cited by this paper
• [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

  2013cited by this paper
• Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808

  2013cited by this paper
• Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education

  2013cited by this paper
• Biomarker modeling of Alzheimer's disease.

  2013cited by this paper
• Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

  2013cited by this paper
• WEIGHT LOSS, ENCEPHALOPATHY, URINARY DIFFICULTIES AND NUMB FEET IN A NIGERIAN MAN

  2013cited by this paper
• Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.

  2013cited by this paper
• Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series

  2013cited by this paper
• Brain amyloid imaging.

  2013cited by this paper
• The Neglected Role of Histamine in Alzheimer’s Disease

  2013cited by this paper
• In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects

  2013cited by this paper
• Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.

  2013cited by this paper
• A semi-quantitative method for correlating brain disease groups with normal controls using SPECT: Alzheimer's disease versus vascular dementia

  2013cited by this paper
• Clinical use of brain volumetry

  2013cited by this paper
• Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

  2013cited by this paper
• PET scanning of brain tau in retired national football league players: preliminary findings.

  2013cited by this paper
• Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.

  2013cited by this paper
• Brain β-amyloid load approaches a plateau

  2013cited by this paper
• Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals

  2013cited by this paper
• The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia

  2013cited by this paper
• Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association

  2013cited by this paper
• The spectrum of disease in chronic traumatic encephalopathy.

  2013cited by this paper
• An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease

  2012cited by this paper
• Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

  2012cited by this paper
• &bgr;-Amyloid burden in healthy aging: Regional distribution and cognitive consequences

  2012cited by this paper
• National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

  2012influential reference
• Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease

  2012cited by this paper
• Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment

  2012cited by this paper
• PET Imaging of Nicotinic Acetylcholine Receptors in Baboons with 18F-AZAN, a Radioligand with Improved Brain Kinetics

  2012cited by this paper
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

  2012cited by this paper
• Comparison of International Working Group criteria and National Institute on Aging–Alzheimer's Association criteria for Alzheimer's disease

  2012influential reference
• Brain amyloid and cognition in Lewy body diseases

  2012cited by this paper
• Cortical Thinning in Subcortical Vascular Dementia with Negative 11C-PiB PET

  2012cited by this paper
• Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma

  2012cited by this paper
• Cognitive Profile of Amyloid Burden and White Matter Hyperintensities in Cognitively Normal Older Adults

  2012cited by this paper
• Imaging of Microglia in Patients with Neurodegenerative Disorders

  2012cited by this paper
• Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

  2012influential reference
• Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement.

  2012cited by this paper
• Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

  2012cited by this paper
• Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

  2012cited by this paper
• PET imaging in the differential diagnosis of vascular dementia.

  2012cited by this paper
• Neurodegenerative Diseases

  2012cited by this paper
• Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics.

  2012cited by this paper
• [3H]Chiba‐1001(methyl‐SSR180711) has low in vitro binding affinity and poor in vivo selectivity to nicotinic alpha‐7 receptor in rodent brain

  2012cited by this paper
• Multiple Pathologies are Common in Alzheimer Patients in Clinical Trials

  2012cited by this paper
• Cognition, glucose metabolism and amyloid burden in Alzheimer's disease.

  2012cited by this paper
• Development of positron emission tomography β-amyloid plaque imaging agents.

  2012cited by this paper
• Amyloid deposition, hypometabolism, and longitudinal cognitive decline

  2012cited by this paper
• Classification of primary progressive aphasia and its variants

  2011cited by this paper
• Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B

  2011cited by this paper
• Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging

  2011cited by this paper
• Verification of predicted robustness and accuracy of multivariate analysis

  2011cited by this paper
• Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

  2011cited by this paper
• Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma.

  2011cited by this paper
• Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011influential reference
• Amyloid‐beta plaque growth in cognitively normal adults: Longitudinal [11C]Pittsburgh compound B data

  2011cited by this paper
• Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.

  2011cited by this paper
• Brain Amyloid Imaging

  2011cited by this paper
• Histamine Pharmacology and New CNS Drug Targets

  2011cited by this paper

• Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy?

  2025cites this paper
• Brain

  2021cites this paper
• Traumatic Brain Injury as a Risk Factor for Dementia and Alzheimer Disease: Critical Review of Study Methodologies

  2019cites this paper
• Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers

  2018cites this paper
• The Extracellular Matrix as a Target for Biophysical and Molecular Magnetic Resonance Imaging

  2018cites this paper
• Geriatric Diagnostic Imaging

  2018cites this paper
• Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes

  2017cites this paper
• Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

  2017cites this paper
• What Can Be and What Cannot Be Accomplished With PET: Rectifying Ongoing Misconceptions

  2017cites this paper
• A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior

  2017cites this paper
• 'We Need to Protect the Brain': Addressing the Growing Problem of Chronic Traumatic Encephalopathy

  2016cites this paper
• Clinical Positron Emission Tomography (PET) Neuroimaging: Advantages and Limitations as a Diagnostic Tool.

  2016cites this paper
• Guest Editorial.

  2016cites this paper
• FTIR Spectroscopy - A Potential Tool to Identify Metabolic Changes in Dementia Patients

  2016cites this paper
• Nuclear Medicine Methods in Dementia

  2016cites this paper
• Molecular Imaging Approaches to the Evaluation of Infectious Diseases- A Prospective Assessment

  2016cites this paper
• Traumatic brain injuries

  2016cites this paper